AG
VYGR icon

Advisor Group’s Voyager Therapeutics VYGR Stock Holding History

Advisor Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Buy
+119
New +$1.73K ﹤0.01% 5033
2019
Q3 		– Sell
-400
Closed -$11K – 5443
2019
Q2 		$11K Hold
400
– – ﹤0.01% 4336
2019
Q1 		$8K Buy
+400
New +$5.21K ﹤0.01% 4489
2018
Q4 		– Sell
-1,100
Closed -$21K – 5249
2018
Q3 		$21K Buy
+1,100
New +$21.1K ﹤0.01% 3877

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Advisor Group's VYGR Position: Q4 2019 in Review

Advisor Group opened a new position in Voyager Therapeutics (VYGR) in Q4 2019: 119 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #5033 among its holdings. This is a return to the name: Advisor Group previously reported a position in VYGR as recently as Q2 2019.

Advisor Group first reported a position in VYGR in Q3 2018 and has held it in 4 quarters since. The position peaked at $21K in Q3 2018. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

  • Advisor Group held 119 shares of Voyager Therapeutics worth $2K as of Q4 2019.
  • Voyager Therapeutics was a new Advisor Group position in Q4 2019.
  • Voyager Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5033 holding.
  • Advisor Group first reported a position in Voyager Therapeutics in Q3 2018 and has held it in 4 quarters since.
  • Advisor Group's Voyager Therapeutics position peaked at $21K in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.